Virtici

Phase 2

San Francisco, United StatesFounded 2019virtici.com

Virtici LLC, a life science innovation and product development company, today announced that it has been awarded a Phase 2 Small Business Innovation Research (SBIR) grant from the National Institute of Dental and Craniofacial Research (NIDCR) of the National Institutes of Health (NIH) to advance VTC-880, a first-in-class peptide for the prevention and treatment of periodontitis.

Founded

2019

Focus

Digital HealthAI / Machine Learning

About

Virtici LLC, a life science innovation and product development company, today announced that it has been awarded a Phase 2 Small Business Innovation Research (SBIR) grant from the National Institute of Dental and Craniofacial Research (NIDCR) of the National Institutes of Health (NIH) to advance VTC-880, a first-in-class peptide for the prevention and treatment of periodontitis.

Company Info

TypePrivate

Founded2019

LocationSan Francisco, United States

StagePhase 2

Contact

Sectors

Small Molecule Drugs

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.